SCOTTY COMBS: Open Payments
NPI 1730317561 · JACKSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 30 payments from 10 companies in 2025. Trend: 2023 $660 · 2024 $545 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| Amgen Inc. | 3 | $54 |
| Exact Sciences Corporation | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| Novo Nordisk Inc | 3 | $43 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| KYOWA KIRIN, INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: QULIPTA, CAPLYTA, Cologuard Collection Kit, Kerendia, Ozempic, TRELEGY ELLIPTA, OTEZLA, VRAYLAR.
Industry payments across KY — which companies pay providers there.
